NASDAQ:AMEHApollo Medical Stock Price, Forecast & News

Apollo Medical's stock was trading at $14.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AMEH stock has increased by 27.1% and is now trading at $17.88. View which stocks have been most impacted by Coronavirus.

Apollo Medical is scheduled to release its next quarterly earnings announcement on Friday, August 14th 2020. View our earnings forecast for Apollo Medical.

Apollo Medical Holdings Inc (NASDAQ:AMEH) posted its quarterly earnings data on Wednesday, May, 27th. The company reported $0.11 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.04 by $0.07. The business earned $165.11 million during the quarter. Apollo Medical had a return on equity of 10.20% and a net margin of 2.86%. View Apollo Medical's earnings history.

Apollo Medical issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, March, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $665-675 million, compared to the consensus revenue estimate of $664 million.

Press coverage about AMEH stock has trended very negative on Friday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Apollo Medical earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near future. View the latest news aboutApollo Medical.

Apollo Medical saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 523,000 shares, a decline of 6.9% from the April 30th total of 561,600 shares. Based on an average daily volume of 61,700 shares, the days-to-cover ratio is presently 8.5 days. Currently, 2.9% of the shares of the stock are short sold. View Apollo Medical's Current Options Chain.

Some companies that are related to Apollo Medical include NIC (EGOV), ICF International (ICFI), Huron Consulting Group (HURN), RMR Group (RMR), The Hackett Group (HCKT), Diamond Eagle Acquisition (ATCX), Blackrock Capital Investment (BKCC), Avalon Globocare (AVCO), Information Services Group (III), ATIF (ATIF), Wilhelmina International (WHLM), Pharma Bio Serv (PBSV), Lightbridge (LTBR), TSS (TSSI) and China Internet Nationwide Fncl Srvcs (CIFS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include Paypal (PYPL), SEA (SE), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), NVIDIA (NVDA), Okta (OKTA), Alibaba Group (BABA), Mastercard (MA), Invesco QQQ Trust (QQQ) and Exxon Mobil (XOM).

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Apollo Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (2.51%), Geode Capital Management LLC (0.56%), State Street Corp (0.42%), THB Asset Management (0.35%), Bank of New York Mellon Corp (0.17%) and Nuveen Asset Management LLC (0.11%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied, Thomas S Lam and Warren Hosseinion. View institutional ownership trends for Apollo Medical.

AMEH stock was sold by a variety of institutional investors in the last quarter, including Virginia Retirement Systems ET AL, WINTON GROUP Ltd, THB Asset Management, Wells Fargo & Company MN, State Street Corp, Manchester Financial Inc., UBS Group AG, and Bank of New York Mellon Corp. View insider buying and selling activity for Apollo Medical.

AMEH stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., JPMorgan Chase & Co., Geode Capital Management LLC, Nuveen Asset Management LLC, Zebra Capital Management LLC, Alliancebernstein L.P., BNP Paribas Arbitrage SA, and Martingale Asset Management L P. Company insiders that have bought Apollo Medical stock in the last two years include Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied, and Thomas S Lam. View insider buying and selling activity for Apollo Medical.

Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AMEH stock can currently be purchased for approximately $17.88.

Apollo Medical has a market capitalization of $949.02 million and generates $560.62 million in revenue each year. The company earns $14.12 million in net income (profit) each year or $0.43 on an earnings per share basis. Apollo Medical employs 475 workers across the globe.

The official website for Apollo Medical is www.apollomed.net.

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The company can be reached via phone at 626-282-0288 or via email at [email protected]